Literature DB >> 6969150

Alteration in T lymphocyte subpopulations in inflammatory bowel disease.

R M Victorino, H J Hodgson.   

Abstract

Peripheral blood mononuclear cells from thirty-one patients with inflammatory bowel disease (ulcerative colitis and Crohn's disease) were analysed for the proportions and absolute numbers of total T cells, and for the T cell subpopulations carrying Fc receptors for either IgM (Tmu cells) or IgG (T gamma cells). Twenty-six control subjects were studied simultaneously. Total T cell numbers were normal in patients with inflammatory bowel disease but there was a marked reduction in the proportion and absolute numbers of Tmu cells in patients, whether their disease was active or in remission. T gamma cells were normal. Simultaneous assessment of lymphocyte response to mitogens in vitro was performed in a group of patients. Responses to phytohaemagglutinin, concanavalin A and pokeweed mitogen were decreased and a positive correlation was found between the number of circulating Tmu cells and the responses to mitogens in vitro. These studies demonstrate that despite the presence of normal numbers of total T cells in inflammatory bowel disease, there is a marked imbalance in T cell subpopulations that correlates with mitogen responsiveness. This imbalance provides a possible cellular basis for the defect in cell-mediated immunity seen in these patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969150      PMCID: PMC1536922     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  45 in total

1.  Impaired lymphocyte reactivity against tumour cells in patients with Crohn's disease.

Authors:  B P Maclaurin; W T Cooke; N R Ling
Journal:  Gut       Date:  1972-08       Impact factor: 23.059

2.  Lymphocyte transformation and delayed hypersensitivity in Crohn's disease.

Authors:  C Röpke
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

3.  Inflammatory bowel disease: lymphocytic responses to nonspecific stimulation in vitro.

Authors:  J Aas; A Huizenga; A D Newcomer; R G Shorter
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

4.  Investigation of the pathogenic mechanisms in regional enteritis with in vitro lymphocyte cultures.

Authors:  K Parent; J Barrett; I D Wilson
Journal:  Gastroenterology       Date:  1971-10       Impact factor: 22.682

5.  An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.

Authors:  W Boyle
Journal:  Transplantation       Date:  1968-09       Impact factor: 4.939

6.  Immunological studies in ulcerative colitis. 3. Incidence of antibodies to colon-antigen in ulcerative colitis and other gastro-intestinal diseases.

Authors:  R Lagercrantz; S Hammarström; P Perlmann; B E Gustafsson
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

7.  Delayed hypersensitivity and lymphocyte transformation in Crohn's disease and proctocolitis.

Authors:  J G Walker; M F Greaves
Journal:  Gut       Date:  1969-05       Impact factor: 23.059

8.  Development of delayed hypersensitivity to dinitrochlorobenzene in patients with Crohn's disease.

Authors:  J V Jones; J Housley; P M Ashurst; C F Hawkins
Journal:  Gut       Date:  1969-01       Impact factor: 23.059

9.  Clinical significance of white bile in the biliary tree.

Authors:  R G Elmslie; M E Thorpe; J V Colman; C R Boughton; G R Pritchard; R J Hoy
Journal:  Gut       Date:  1969-07       Impact factor: 23.059

10.  Delayed hypersensitivity in regional enteritis and ulcerative colitis.

Authors:  H J Binder; H M Spiro; W R Thayer
Journal:  Am J Dig Dis       Date:  1966-07
View more
  18 in total

1.  Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors.

Authors:  A Raedler; S Fraenkel; G Klose; H G Thiele
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

2.  Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine.

Authors:  G Holdstock; B F Chastenay; E L Krawitt
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

3.  Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease.

Authors:  G Sieber; F Herrmann; M Zeitz; H Teichmann; H Rühl
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

Review 4.  Characteristics and function of Fc receptors on human lymphocytes.

Authors:  P M Lydyard; M W Fanger
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

5.  Further characterization of lymphocytes from human colonic lamina propria: identification of TG cells.

Authors:  S G ReMine; W Bartnik; R C Bahn; R G Shorter
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

6.  Loss of suppressor T-cells in active inflammatory bowel disease.

Authors:  N J Godin; D B Sachar; R Winchester; C Simon; H D Janowitz
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

7.  The role of TG lymphocytes in cell-mediated immunity in patients with periodontal disease.

Authors:  L Ivanyi; B Topic; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

8.  Controlled therapeutic trial of levamisole and sulphasalazine in acute ulcerative colitis.

Authors:  A Hermanowicz; A Nowak; L Gajos
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

9.  Enumeration of lymphocyte populations defined by surface markers in the whole blood of patients with Crohn's disease.

Authors:  E O Pepys; E A Fagan; G A Tennent; V S Chadwick; M B Pepys
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

10.  Spontaneous suppressor cell activity in the peripheral blood of patients with malignant and chronic inflammatory bowel diseases.

Authors:  K Doldi; B Manger; B Koch; J Riemann; P Hermanek; J R Kalden
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.